Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 348 citing articles:

Pathology and Pathogenesis of Chagas Heart Disease
Kevin M. Bonney, Daniel Luthringer, Stacey A. Kim, et al.
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 421-447
Open Access | Times Cited: 209
An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment
Javier Martín‐Escolano, Clotilde Marı́n, María J. Rosales, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1107-1115
Open Access | Times Cited: 71
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 4, pp. 386-394
Closed Access | Times Cited: 23
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
Julio Alonso-Padilla, Núria Cortes-Serra, María‐Jesús Pinazo, et al.
Expert Review of Anti-infective Therapy (2019) Vol. 17, Iss. 3, pp. 145-157
Open Access | Times Cited: 96
Treatment of Chagas Disease in the United States
Sheba Meymandi, Salvador Hernández, Sandy Park, et al.
Current treatment options in infectious diseases/Current treatment options in infectious disease (2018) Vol. 10, Iss. 3, pp. 373-388
Open Access | Times Cited: 91
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
Bianca Zingales, Daniella Castanheira Bartholomeu
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 57
Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions
Luísa Mourão Dias Magalhães, Kenneth J. Gollob, Bianca Zingales, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 9, pp. e711-e722
Open Access | Times Cited: 49
Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023
José Antônio Marin‐Neto, Anis Rassi, Gláucia Maria Moraes de Oliveira, et al.
Arquivos Brasileiros de Cardiologia (2023) Vol. 120, Iss. 6
Open Access | Times Cited: 39
The epidemiology of Chagas disease in the Americas
Zulma M. Cucunubá, Sebastián A Gutiérrez-Romero, Juan David Ramírez, et al.
The Lancet Regional Health - Americas (2024) Vol. 37, pp. 100881-100881
Open Access | Times Cited: 12
Chagas Disease: A Silent Threat for Dogs and Humans
João Durães-Oliveira, Joana Palma-Marques, Cláudia Jassica Gonçalves Moreno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3840-3840
Open Access | Times Cited: 10
New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes
Marina Malheiros Araújo Silvestrini, Gláucia Diniz Alessio, Bruna Estefânia Diniz Frias, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Trypanosoma cruzi: Genomic Diversity and Structure
Alfonso Herreros‐Cabello, Francisco Callejas‐Hernández, Núria Gironès, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 1
Congenital Chagas disease: The importance of Trypanosoma cruzi-placenta interactions
Christian Castillo, Ana Liempi, Fernández-Moya Alejandro, et al.
Placenta (2025)
Closed Access | Times Cited: 1
Proteomic analysis reveals different composition of extracellular vesicles released by two Trypanosoma cruzi strains associated with their distinct interaction with host cells
Kleber Silva Ribeiro, Camilla Ioshida Vasconcellos, Rodrigo Pedro Soares, et al.
Journal of Extracellular Vesicles (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 73
Congenital Chagas disease: current diagnostics, limitations and future perspectives
Louisa A. Messenger, Caryn Bern
Current Opinion in Infectious Diseases (2018) Vol. 31, Iss. 5, pp. 415-421
Open Access | Times Cited: 67
Why hasn’t there been more progress in new Chagas disease drug discovery?
Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 2, pp. 145-158
Closed Access | Times Cited: 66
In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
Lucas Michel-Todó, Pedro A. Reche, Pascal Bigey, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58
Carbohydrate metabolism in trypanosomatids: New insights revealing novel complexity, diversity and species-unique features
Paul A.M. Michels, Oriana Villafraz, Erika Pineda, et al.
Experimental Parasitology (2021) Vol. 224, pp. 108102-108102
Open Access | Times Cited: 51
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
Ana Lia Mazzeti, Patrícia Capelari-Oliveira, Maria Terezinha Bahia, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 409-432
Open Access | Times Cited: 49
The translational challenge in Chagas disease drug development
Jadel M. Kratz, Karolina Ribeiro Gonçalves, Lavínia MD Romera, et al.
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 38
What Do You Need to Know before Studying Chagas Disease? A Beginner’s Guide
José A. De Fuentes-Vicente, Nancy G. Santos-Hernández, Christian Ruiz-Castillejos, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 7, pp. 360-360
Open Access | Times Cited: 22
Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?
Bianca Zingales, Andréa Mara Macedo
Life (2023) Vol. 13, Iss. 12, pp. 2339-2339
Open Access | Times Cited: 21
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
Alejandro D. Ricci, Leonel Bracco, Emir Salas‐Sarduy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 575-590
Closed Access | Times Cited: 7
Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin
Bruno Amorim-Carmo, Alessandra Daniele-Silva, Adriana M. S. Parente, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 623-623
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top